BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 31677184)

  • 1. Planning mass eradication of Helicobacter pylori infection for indigenous Taiwanese peoples to reduce gastric cancer.
    Bair MJ; Chuang SL; Lei WY; Chen CL; Tian HW; Chiang TH; Su WW; Lin CC; Chung Lo YT; Jou YY; Wu CY; Chia SL; Wu MS; Chen HH; Chu CH; Lee YC; Wang YW
    J Gastroenterol Hepatol; 2020 Apr; 35(4):609-616. PubMed ID: 31677184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reducing the health disparity in gastric cancer: A start by Helicobacter pylori eradication in indigenous peoples living in Taiwan.
    Lin JT
    J Gastroenterol Hepatol; 2020 May; 35(5):705-706. PubMed ID: 32367563
    [No Abstract]   [Full Text] [Related]  

  • 3. Mass eradication of
    Chiang TH; Chang WJ; Chen SL; Yen AM; Fann JC; Chiu SY; Chen YR; Chuang SL; Shieh CF; Liu CY; Chiu HM; Chiang H; Shun CT; Lin MW; Wu MS; Lin JT; Chan CC; Graham DY; Chen HH; Lee YC
    Gut; 2021 Feb; 70(2):243-250. PubMed ID: 32792335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consensus on eradication of Helicobacter pylori and prevention and control of gastric cancer in China (2019, Shanghai).
    Du Y; Zhu H; Liu J; Li J; Chang X; Zhou L; Chen M; Lu N; Li Z
    J Gastroenterol Hepatol; 2020 Apr; 35(4):624-629. PubMed ID: 31788864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk Factors and Incidence of Gastric Cancer After Detection of Helicobacter pylori Infection: A Large Cohort Study.
    Kumar S; Metz DC; Ellenberg S; Kaplan DE; Goldberg DS
    Gastroenterology; 2020 Feb; 158(3):527-536.e7. PubMed ID: 31654635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eradicating
    Lei WY; Lee JY; Chuang SL; Bair MJ; Chen CL; Wu JY; Wu DC; Tien O'Donnell F; Tien HW; Chen YR; Chiang TH; Hsu YH; Hsu TH; Hsieh PC; Lin LJ; Chia SL; Wu CC; Subeq YM; Wen SH; Chang HC; Lin YW; Sun KP; Chu CH; Wu MS; Graham DY; Chen HH; Lee YC
    Gut; 2023 Nov; 72(12):2231-2240. PubMed ID: 37197905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expanded indication of National Health Insurance for H. pylori associated gastritis].
    Kato M
    Nihon Rinsho; 2014 May; 72(5):967-76. PubMed ID: 24912302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Burden of disease from Helicobacter pylori infection in western Canadian Arctic communities.
    Fagan-Garcia K; Geary J; Chang HJ; McAlpine L; Walker E; Colquhoun A; van Zanten SV; Girgis S; Archie B; Hanley B; Corriveau A; Morse J; Munday R; Goodman KJ;
    BMC Public Health; 2019 Jun; 19(1):730. PubMed ID: 31185961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The association between Helicobacter pylori and gastric cancer: the role of infection's eradication. Recent advances].
    Eusebi LH; Ceroni L; Laterza L; Kurelac I; Fuccio L
    Recenti Prog Med; 2010 Feb; 101(2):66-9. PubMed ID: 20433004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Helicobacter pylori and gastric cancer:current status of the Austrain Czech German gastric cancer prevention trial (PRISMA Study).
    Miehlke S; Kirsch C; Dragosics B; Gschwantler M; Oberhuber G; Antos D; Dite P; Läuter J; Labenz J; Leodolter A; Malfertheiner P; Neubauer A; Ehninger G; Stolte M; Bayerdörffer E
    World J Gastroenterol; 2001 Apr; 7(2):243-7. PubMed ID: 11819768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening and treating Helicobacter pylori infection for gastric cancer prevention on the population level.
    Lee YC; Lin JT
    J Gastroenterol Hepatol; 2017 Jun; 32(6):1160-1169. PubMed ID: 28087975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pretreatment antimicrobial susceptibility-guided vs. clarithromycin-based triple therapy for Helicobacter pylori eradication in a region with high rates of multiple drug resistance.
    Park CS; Lee SM; Park CH; Koh HR; Jun CH; Park SY; Lee WS; Joo YE; Kim HS; Choi SK; Rew JS
    Am J Gastroenterol; 2014 Oct; 109(10):1595-602. PubMed ID: 25091062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clarithromycin resistance and female gender affect Helicobacter pylori eradication failure in chronic gastritis.
    Chang YW; Ko WJ; Oh CH; Park YM; Oh SJ; Moon JR; Cho JH; Kim JW; Jang JY
    Korean J Intern Med; 2019 Sep; 34(5):1022-1029. PubMed ID: 29898576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association Between Helicobacter pylori Eradication and Gastric Cancer Incidence: A Systematic Review and Meta-analysis.
    Lee YC; Chiang TH; Chou CK; Tu YK; Liao WC; Wu MS; Graham DY
    Gastroenterology; 2016 May; 150(5):1113-1124.e5. PubMed ID: 26836587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Helicobacter pylori-associated diseases].
    Gisbert JP
    Gastroenterol Hepatol; 2015 Sep; 38 Suppl 1():39-48. PubMed ID: 26520195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levofloxacin-based triple therapy in first-line treatment for Helicobacter pylori eradication.
    Nista EC; Candelli M; Zocco MA; Cremonini F; Ojetti V; Finizio R; Spada C; Cammarota G; Gasbarrini G; Gasbarrini A
    Am J Gastroenterol; 2006 Sep; 101(9):1985-90. PubMed ID: 16968503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Helicobacter pylori eradication. Therapeutic evolution, value of complementary studies].
    Bigard MA
    Presse Med; 2001 Sep; 30(26):1305-12. PubMed ID: 11603094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in the first line Helicobacter pylori eradication rates using the triple therapy-a multicenter study in the Tokyo metropolitan area (Tokyo Helicobacter pylori study group).
    Kawai T; Takahashi S; Suzuki H; Sasaki H; Nagahara A; Asaoka D; Matsuhisa T; Masaoaka T; Nishizawa T; Suzuki M; Ito M; Kurihara N; Omata F; Mizuno S; Torii A; Kawakami K; Ohkusa T; Tokunaga K; Mine T; Sakaki N
    J Gastroenterol Hepatol; 2014 Dec; 29 Suppl 4():29-32. PubMed ID: 25521730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial.
    Wong BC; Lam SK; Wong WM; Chen JS; Zheng TT; Feng RE; Lai KC; Hu WH; Yuen ST; Leung SY; Fong DY; Ho J; Ching CK; Chen JS;
    JAMA; 2004 Jan; 291(2):187-94. PubMed ID: 14722144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of selective COX-2 inhibitor and Helicobacter pylori eradication on precancerous gastric lesions.
    Wong BC; Zhang L; Ma JL; Pan KF; Li JY; Shen L; Liu WD; Feng GS; Zhang XD; Li J; Lu AP; Xia HH; Lam S; You WC
    Gut; 2012 Jun; 61(6):812-8. PubMed ID: 21917649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.